Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

<scp>CHARMM</scp>: A program for macromolecular energy, minimization, and dynamics calculations

Bernard R. Brooks, Robert E. Bruccoleri, Barry D. Olafson et al. · Journal of Computational Chemistry · 1983 · 14.9K citations

Natural Sciences, Chemistry, Biomolecular Modeling +13

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Jessica Caprioli, Marina Noris, Simona Brioschi et al. · Blood · 2006 · 730 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

Mieke Delvaeye, Marina Noris, Astrid De Vriese et al. · New England Journal of Medicine · 2009 · 546 citations · Full text

Medicine, Genetics, Hematology +15

Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome

David Kavanagh, Elizabeth J. Kemp, Elizabeth Mayland et al. · Journal of the American Society of Nephrology · 2005 · 476 citations

Life Sciences, Genetics, Molecular Genetics +16

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

Elena Goicoechea de Jorge, Claire L. Harris, Jorge Esparza-Gordillo et al. · Proceedings of the National Academy of Sciences · 2006 · 445 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16